Microchip Appoints Chief Operating Officer
News Oct 21, 2005
Microchip Biotechnologies Inc. has announced that it has named Dr. Barney E. Saunders as its Chief Operating Officer.
Most recently Dr. Saunders held positions at Agilent Technologies, within their Life Sciences and Chemical Analysis division, as General Manager and Vice President, Bioresearch Solutions, and Senior Director, Science and Technology.
Prior to this Dr. Saunders spent thirteen years at Amersham Biosciences in Europe and North America where he held a variety of commercial and marketing positions.
“I am delighted to have Barney join our team,” said Stevan Jovanovich, President and CEO of MBI.
“His knowledge of the Life Sciences industry and experience in taking breakthrough technologies to market will be of great value as MBI begins to commercialize our NanoBioProcessor™ technology.”
“Microchip Biotechnologies has exceptional technology and a team well- versed in developing cutting edge instrumentation,” said Dr. Saunders.
“I am looking forward to working with Stevan and the rest of MBI's team to bring much needed nanofluidic sample preparation products that will become front- ends to current and future analytical instruments serving the Life Sciences and Biodefense industries.”
Saunders was educated in England and received a Bachelor of Sciences in Biological Sciences and a Ph.D. in Molecular Biology from the University of Birmingham, UK.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE